Perbedaan Bank Mayapada Internasional Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Bank Mayapada Internasional Tbk. diperdagangkan di Rp197 (kapitalisasi pasar 5,08 T, volume 24 jam 476,3 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Bank Mayapada Internasional Tbk. jauh lebih besar — sekitar 30,6× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Bank Mayapada Internasional Tbk. lebih aktif diperdagangkan (476,3 rb vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MAYA | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 5,08 T | 166,01 M |
Volume | 476,3 rb | 324 rb |
Lot | 4,76 rb | 3,24 rb |
Perputaran | 92,84 jt | 77,68 jt |
Harga Rata-rata | 194,91 | 239,75 |
Nilai Transaksi | 92,84 jt | 77,68 jt |
Harga Ekuilibrium Indikatif | 197 | 240 |
Volume Ekuilibrium Indikatif | 17 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Bank Mayapada Tbk (the Company) was established based on Notarial Deed OF notary Edison Jingga, SH No 196 dated September 7, 1989 by the Notary Edison Jingga, SH., substitute for Misahardi Wilamarta, SH.By September 22, 1999 the bank increased its authorized capital from Rp 300,000,000,000 to Rp 650,000,000,000 which consits of 1,300,000,000 shares with nominal value of Rp 500 per share.
Selengkapnya di halaman MAYA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →